Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes

Metformin is typically the first pharmacologic treatment recommended for type 2 diabetes mellitus (T2DM), but many patients do not achieve glycemic control with metformin alone and eventually require combination therapy with other agents. Canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Rong, Balis, Dainius, Capuano, George, Xie, John, Meininger, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118239/
https://www.ncbi.nlm.nih.gov/pubmed/27734320
http://dx.doi.org/10.1007/s13300-016-0201-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118239/
https://www.ncbi.nlm.nih.gov/pubmed/27734320
http://dx.doi.org/10.1007/s13300-016-0201-z

Ejemplares similares